Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 3Lung Neoplasms 2Esophageal Neoplasms 2Stomach Neoplasms 1Pediatric Brain Tumor 1Insulin Resistance 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Disease 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13Docetaxel 13sintilimab 12Drug Therapy 12Trastuzumab 11tislelizumab 10Cisplatin 10Irinotecan 9Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Hyperthermic Intraperitoneal Chemotherapy 7Biopsy 7fludarabine 6disitamab vedotin 6Cyclophosphamide 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × High-Intensity Interval Training × Clear all
NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

Kansai Medical University

Phase NA Recruiting
171 enrolled
Gastrointestinal

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡